The Latest Breaking News from CDC

With a potential second booster on the horizon for vulnerable groups, the White House is still struggling to drum up interest for additional shots – and funding

The U.S. Food and Drug Administration is poised to clear a fourth dose of the mRNA coronavirus vaccine for adults age 50 and older, looking to shore up protections for more vulnerable groups, a person familiar with the matter said.

BA.2 subvariant now accounts for nearly 55 per cent of confirmed infections in US

Pfizer and Moderna seek approval for second ‘booster’ doses as White House warns US has exhausted funding to buy more shots

Experts are watching for a potential new COVID-19 surge in the U.S. — and wondering how long it will take to detect

COVID-19 rates are plunging among migrants crossing the border from Mexico as the Biden administration faces a decision to end or extend sweeping restrictions on asylum that are aimed at limiting the virus’ spread

MODESTO, CALIFORNIA — Una de las primeras tareas del día de Patrick Green es abrir un grifo y llenar una botella con lodo.

Pfizer and Moderna seek approval for second ‘booster’ doses as White House warns US has exhausted funding to buy more shots

The Centers for Disease Control and Prevention (CDC) has granted a contract to Quest Diagnostics Inc (NYSE:DGX) to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis.  Quest was awarded the contract following a competitive bid. The total contract value with all options is valued…

Here's a roundup of top developments in the biotech space over the last 24 hours:

Calls for agency to communicate clearly and transparently after error, corrected last week, inadvertently added deaths to tracker